A transforming mutation in the PH domain of Akt1 is associated with breast, colorectal and lung cancers; this mutation activates Akt1 by allowing its recruitment to membranes independently of its PtdIns(3,4)P2 and PtdIns(3,4,5)P3 binding [127]. This evidence concerns the gene AKT1 and lung cancer.